谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.
研究兴趣

论文共 86 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Erratum to “INTERCEPT-AD, a Phase 1 Study of Intravenous Sabirnetug in Participants with Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease” [J Prev Alzheimers Dis 2025;12(1): 100005.]
Eric Siemers, Todd Feaster,Gopalan Sethuraman, Karen Sundell, Vladimir Skljarevski, Erika N Cline, Hao Zhang,Jasna Jerecic, Lawrence S Honig, Stephen Salloway, Reisa Sperling, Mirjam N Trame, Michael G Dodds, Kimball Johnson
The journal of prevention of Alzheimer's diseasepp.100213-100213, (2025)
引用0浏览0WOS引用
0
0
A Phase 1 Study, INTERCEPT-AD, of ACU193: Safety, Target Engagement, and Biomarker Changes
Eric Siemers, Erika Cline,Todd Feaster, Vladimir Skljarevski,Karen Sundell,Daniel Antwi-Berko, Marleen Koel-Simmelink,Charlotte Teunissen, Hao Zhang,Gopalan Sethuraman, Jerome Moore, Hugo Vanderstichele,June Kaplow, Robert Dean,Jasna Jerecic
NEUROLOGYno. 12 (2024): S13-S14
引用0浏览0引用
0
0
Sabirnetug (ACU193) Lowers CSF Levels of Synaptic Biomarkers in INTERCEPT‐AD Phase 1 Study in Early AD
Erika N Cline, Elizabeth Johnson,Karen Sundell,Daniel Antwi‐Berko, Marleen JA Koel‐Simmerlink,Charlotte Teunissen,Eric Siemers, Hao Zhang, Maddelyn Hyland,Gopalan Sethuraman, Hugo Vanderstichele,June Kaplow,Robert A Dean,Jasna Jerecic
Alzheimer's &amp Dementiano. S8 (2024)
引用0浏览0引用
0
0
Recruitment Strategies and Tactics for INTERCEPT‐AD: A Phase I Trial of Aβ Oligomer‐targeting ACU193 in Early Alzheimer’s Disease
Robyn Moxon,Todd Feaster, Alyssa Carroll, Siew Tin Gan, Shane Ziemba, Kimber Price, Vladimir Skljarevski,Karen L Sundell,Gopalan Sethuraman,Janice Hitchcock,Eric R Siemers
Alzheimer s & Dementiano. S24 (2023)
引用0浏览0引用
0
0
加载更多
作者统计

#Papers: 86

#Citation: 4047

H-Index: 29

G-Index: 55

Sociability: 6

Diversity: 3

Activity: 11

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn